Dr. Arman Rahmim
Dr. Rahmim is Professor of Radiology and Physics at the University of British Columbia (UBC) as well as Distinguished Scientist and Provincial Medical Imaging Physicist at BC Cancer. Following doctoral studies at UBC, he was recruited by Johns Hopkins University (JHU) in 2005 to pursue research at the JHU Department of Radiology and to lead the high resolution brain PET imaging physics program. In 2018, he was recruited back to Vancouver, where his laboratory pursues interdisciplinary research towards discovery of enhanced biomarkers of cancer from quantitative nuclear medicine imaging modalities (PET and SPECT). He also leads a provincial PET physics program at BC Cancer, and aims to develop solutions that can transform clinical practice and make a difference in healthcare and in people’s lives.
Lab website: www.Qurit.ca
Dr. Paul Schaffer
Dr. Schaffer is the head of TRIUMF's Nuclear Medicine division.
Dr. Donald Yapp
Our group has interests in non-invasive imaging to elucidate tumour physiology and function as the disease progresses or responds to treatment. The group is also affiliated with Pancreas Cancer BC and we have on-going studies with pancreatic cancer patient derived xenografts as pre-clinical test-beds for a variety of projects. We are also working with groups at SFU on developing and characterizing nanoparticle platforms based on gold and iron-oxide for targeted, on-demand drug delivery using external energy sources.
Lab website: https://www.bccrc.ca/dept/et/people/donald-yapp
Dr. Haishan Zeng
Dr. Haishan Zeng is a distinguished scientist with the Integrative Oncology Department (Imaging Unit) of the BC Cancer Agency Research Centre, a professor of Dermatology and Skin Science at the University of British Columbia (UBC), and associate member of UBC Departments of Pathology & Laboratory Medicine and Physics & Astronomy. For over 28 years, Dr. Zeng’s research has been focused on developing various optical imaging and spectroscopy techniques for improving early cancer detection. He has published over 151 refereed journal papers, 1 book, 17 book chapters, and has 25 granted patents related to optical diagnosis and therapy. Several medical devices derived from these patents have passed regulatory approvals and are currently in clinical uses around the world. The latest device, Verisante Aura™ using Raman spectroscopy for non-invasive skin cancer detection, was awarded the Prism Award in the Life Sciences and Biophotonics category in February, 2013 by SPIE, the International Society for Optics and Photonics.
Research Key Words: Biomedical Optics, Bionanophotonics, Optical Spectroscopy and Imaging, Phototherapy, Early Cancer Detection.
Lab website: https://www.bccrc.ca/dept/io/people/haishan-zeng